touchPODCAST

MDT perspectives on the role of biomarkers in informing immune checkpoint inhibitor use across tumour types

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team review the role of biomarkers in informing immune checkpoint inhibitor use across tumour types.

The multidisciplinary team

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
• Pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Heidelberg, Germany

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-in-solid-tumours/

 

MDT perspectives on strategies for identifying and monitoring immune-related adverse events

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events.

The multidisciplinary team:

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
• Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK
• Clinical oncology pharmacist: Dr Alison Palumbo, Oregon Health and Science University, Portland, OR, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-in-solid-tumours/

 

MDT perspectives on indications for immune checkpoint inhibitors in patients with solid tumours

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the current and upcoming indications for immune checkpoint inhibitors in patients with solid tumours and review general considerations for their use.

The multidisciplinary team:

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
• Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-in-solid-tumours/

 

Adverse event identification and management in locally advanced/metastatic urothelial carcinoma

touchPANEL DISCUSSION for touchONCOLOGY

Listen to an oncologist, urologist and nurse discuss adverse event identification and management with immunotherapies and targeted therapies for locally advanced or metastatic urothelial carcinoma. 

The experts:

• Dr Axel Merseburger, University Hospital Schleswig-Holstein, Campus Lübeck, Germany
• Dr André Fay, PUCRS School of Medicine, Porto Alegre, Brazil
• Ms Maria Lapuente, St Bartholomew’s Hospital, London, UK
  

This touchPODCAST is for HCPs outside the US only. 

This activity is funded by an independent medical education grant from Astellas Inc. and Seagen Inc., and is jointly provided by USF Health and touchIME.

For further information please visit: https://touchoncologyime.org/adverse-event-identification-and-management-in-locally-advanced-metastatic-urothelial-carcinoma

Experts in infectious diseases discuss the practical considerations for COVID-19 vaccination in the Middle East

touchIN CONVERSATION for touchINFECTIOUS DISEASES

Listen to Dr Farhan Fazal (Sheikh Khalifa Medical City Hospital, Abu Dhabi, UAE) in conversation with Dr Nada Melhem (American University of Beirut, Beirut, Lebanon). They respond to questions submitted by the HCP audience and provide their expert insights on COVID-19 vaccination challenges and strategies for improving vaccine uptake in the Middle East.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Moderna, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchinfectiousdiseasesime.org/in-conversation-practical-considerations-covid19-vaccination-middle-east/

Part 1 - Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals

touchEXPERT OPINIONS for touchENDOCRINOLOGY

In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology.

The experts:

• Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
• Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

This touchPODCAST is for HCPs only.

 This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.

For further information visit: https://touchendocrinologyime.org/radiopharmaceuticals-adult-oncology-primer/

Part 1 - Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals

touchEXPERT OPINIONS for touchONCOLOGY

In this first of a two-part series, a medical physicist and a radiation oncologist provide a scientific and clinical primer on radiopharmaceuticals in adult oncology.

The experts:

• Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
• Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A. This activity is jointly provided by USF Health and touchIME.

For further information visit: https://touchoncologyime.org/radiopharmaceuticals-adult-oncology-primer/ 

Experts in infectious diseases discuss the practical considerations for COVID-19 vaccination in Africa

touchIN CONVERSATION for touchINFECTIOUS DISEASES

Listen to Dr John Amuasi (Kwame Nkrumah University of Science and Technology, Kumasi, Ghana) in conversation with Dr Christina Obiero (Kenya Medical Research Institute, Kilifi, Kenya). They respond to questions submitted by the HCP audience and provide their expert insights on COVID-19 vaccination challenges and strategies for improving vaccine uptake in Africa.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Moderna, Inc. This activity was led by USF Health and touchIME. 

For further information visit our website: https://touchinfectiousdiseasesime.org/in-conversation-practical-considerations-covid19-vaccination-africa

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management

touchEXPERT OPINIONS for touchONCOLOGY

Listen to three leading experts sharing their perspectives on the impact of the 2022 guideline updates on diagnosis, classification and management of higher-risk myelodysplastic neoplasms (MDS) and acute myeloid leukaemia (AML).

 The experts:

• Prof. Andrew Wei, Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
• Prof. Agnieszka Wierzbowska, Medical University of Lodz, Poland
• Prof. Gert Ossenkoppele, Vrije Universiteit University Medical Center, Amsterdam, Netherlands

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Novartis and is provided by touchIME. 

For further information visit: www.touchoncology.com/education/impact-of-new-guidelines-in-MDS-AML 

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management

touchEXPERT OPINIONS for touchHAEMATOLOGY

Listen to three leading experts sharing their perspectives on the impact of the 2022 guideline updates on diagnosis, classification and management of higher-risk myelodysplastic neoplasms (MDS) and acute myeloid leukaemia (AML).

 The experts:

• Prof. Andrew Wei, Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
• Prof. Agnieszka Wierzbowska, Medical University of Lodz, Poland
• Prof. Gert Ossenkoppele, Vrije Universiteit University Medical Center, Amsterdam, Netherlands

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Novartis and is provided by touchIME. 

For further information visit: www.touchhaematology.com/education/impact-of-new-guidelines-in-MDS-AML